RAPT Therapeutics, Inc. - RAPT
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | ORBIMED ADVISORS LLC | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Roderick Wong | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 5.9% | 1,637,165 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Roderick Wong | 5.9% | 1,637,165 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Capital, LP | 0.4% | 110,448 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 0.4% | 110,448 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | David Kroin | 0.4% | 110,448 | View |
| Feb 09, 2026 | SCHEDULE 13G | Glazer Capital, LLC | 5.36% | 1,486,094 | View |
| Feb 09, 2026 | SCHEDULE 13G | Paul J. Glazer | 5.36% | 1,486,094 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.